OMALIZUMAB
omalizumab 300 mg/2 mL injection, 2 mL pen device
OMALIZUMAB (14951X)
14951X
Manner of administration:Injection
Restriction
Indication: Uncontrolled severe asthma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 5 | DPMQ: $443.75 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Xolair | |||||